The Canadian Opioid Crisis: A Closer Look at Xylazine
The Canadian opioid crisis is intensifying, with the emergence of Xylazine as a dangerous substance. Efforts are being made to combat these issues.
The Canadian opioid crisis is intensifying, with the emergence of Xylazine as a dangerous substance. Efforts are being made to combat these issues.
British Columbia’s “safe supply” program aims to address the opioid crisis by providing prescribed alternatives to street drugs.
The opioid crisis in Canadian First Nations communities has dire effects on health, culture, and future generations. More culturally-sensitive interventions are needed.
The Canadian opioid crisis has had devastating effects, contributing to homelessness, rising crime rates, and straining the healthcare system. A lawsuit reveals hypocrisy in British Columbia’s handling of the crisis while the use of naloxone provides some hope. A comprehensive approach is needed to address the root causes and rectify past policy mistakes.
PursueCare, a telehealth provider, has secured $20 million in funding and acquired addiction treatment apps to address Canada’s opioid crisis.
The opioid crisis in Canada requires a multifaceted approach, such as uOttawa’s Campus Naloxone Program, to address health, economic, and social impacts.
BC’s lawsuit against opioid makers while purchasing generic opioids for drug assistance programs exposes hypocrisy in their approach to the opioid crisis.
Understanding the Canadian Opioid Crisis Amidst the Pandemic highlights the escalating crisis and the urgency for action to combat the impacts of opioid use in Canada.
The Canadian opioid crisis continues to devastate the nation, with increasing rates of addiction, crime, and homelessness. Naloxone is proving to be a crucial tool in combatting overdoses.
Fentanyl strain resistant to naloxone poses a significant challenge in the Canadian opioid crisis, increasing overdose risks and straining the healthcare system.